The concentrations of cefepime in pancreatic pseudocyst fluid (n = 4), panc
reatic tissue (n = 4) and pancreatic fistula fluid (n = 1), and simultaneou
s plasma concentrations, were measured after intravenous administration of
a single 2 g dose to nine patients. Mean plasma concentration was 27.4 mg/L
between 120 and 200 min after the end of infusion. Mean pancreatic cefepim
e concentration was 6.3 mg/L in pseudocyst and 10.7 mg/L in pancreatic tiss
ue. Cefepime was detected by 30 min after the end of the perfusion in pancr
eatic fistulae fluid, and persisted at 8 h, We conclude that cefepime is a
potentially useful antibiotic in prevention and treatment of pancreatic inf
ection.